Laura Keller

ORCID: 0000-0002-1786-9760 · 5 papers in corpus
2025
P-376 Oocyte accumulation program in young women at high risk of ovarian injury due to endometriomas or benign ovarian tumors: intermediate results from a prospective study
·doi:10.1093/humrep/deaf097.682

Abstract Study question Is oocyte accumulation for fertility preservation a good option for young women with benign ovarian tumors (BOT) in terms of feasibility, compliance and efficiency? Summary answer Oocyte accumulation may be safely of…

observational 2024
Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-024-01322-7

RESEARCH QUESTION: To determine whether the use of oral dydrogesterone (DYD) in luteal phase support (LPS) during an artificial cycle provides equivalent clinical and ongoing pregnancy, delivery and miscarriage rates as micronized vaginal p…

observational 2022
Polycystic ovary syndrome phenotype does not have impact on oocyte morphology
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00874-2

PURPOSE: The primary objective of the present study of women participating in an ICSI program was to determine whether the morphologic quality of oocytes was related to the polycystic ovary syndrome (PCOS) phenotype. METHODS: We performed …

observational 2022
Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1039579

OBJECTIVE: The need of luteal support after FET is no longer to be proven. Different routes of progesterone administration are available with interindividual differences in metabolization and serum progesterone levels, the latter being high…

observational 2021
Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2021.04.020

RESEARCH QUESTION: What are ovarian stimulation cycle outcomes and acceptance rates of an oocyte accumulation programme in young women with benign ovarian tumour (BOT)? DESIGN: Retrospective cohort study conducted at the Academic Assisted …